InMed Pharmaceuticals Inc (INM)
NASDAQ
The current INM market cap is 2.49M. The company's latest EPS is USD -0.9510 and P/E is -0.30.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.03M | 2.31M | 902k | 1.24M | 1.17M |
Operating Income | -2.73M | -517k | -2.63M | -1.53M | -2.06M |
Net Income | -2M | -339k | -2.54M | -1.48M | -1.72M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 1.09M | 4.14M |
Operating Income | -13.64M | -9.15M | -9.94M | -17.27M | -8.38M |
Net Income | -13.26M | -8.94M | -10.2M | -18.6M | -7.95M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 14.73M | 14.11M | 10.92M | 15.26M | 13.36M |
Total Liabilities | 2.34M | 2.02M | 1.34M | 2.48M | 2.25M |
Total Equity | 12.39M | 12.09M | 9.58M | 12.77M | 11.11M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 19.79M | 7.8M | 9.78M | 12.79M | 14.11M |
Total Liabilities | 1.56M | 1.93M | 2.41M | 3.71M | 2.02M |
Total Equity | 18.23M | 5.88M | 7.38M | 9.08M | 12.09M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.63M | -7.28M | -2.17M | -4.02M | -5.96M |
Investing | -628k | -662k | N/A | -9k | -9k |
Financing | 10.68M | 10.68M | N/A | 4.65M | 4.65M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.77M | -7.38M | -9.79M | -15.58M | -7.28M |
Investing | -2.76M | 3.79M | -2k | -673k | -662k |
Financing | 273k | -31k | 10.86M | 15.07M | 10.68M |
Market Cap | 2.49M |
Price to Earnings Ratio | -0.30 |
Price to Sales Ratio | 0.59 |
Price to Cash Ratio | 0.27 |
Price to Book Ratio | 0.2 |
Dividend Yield | - |
Shares Outstanding | 8.36M |
Average Volume (1 week) | 3.98M |
Average Volume (1 Month) | 1.4M |
52 Week Change | -73.91% |
52 Week High | 2.08 |
52 Week Low | 0.2122 |
Spread (Intraday) | 0.01 (2.18%) |
Company Name | InMed Pharmaceuticals Inc |
Address |
340 - 200 granville street vancouver, british columbia V6C 1S4 |
Website | https://www.inmedpharma.com |
Industry | security systems service (7382) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.